MAPS submitted a short letter
MAPS submitted a short letter to the Western IRB’s Executive Policy Committee, in advance of its November 19 meeting at which it will discuss its review of MAPS’ MDMA/PTSD protocol. The letter …
MP1: Proof Of Principle Study
A Surprising New Issue
After reviewing MAPS’ letter, Dr. James Baldwin of the WIRB informed Rick Doblin that the October 30 meeting was canceled, but not for the reasons MAPS had hoped. Dr. James Baldwin said that the …
A Comprehensive, Strong Response
MAPS submitted a lengthy written response to the WIRB letter, along with 14 letters of information and support from MDMA scientists around the world. MAPS’ letter addressed every point raised in …
A Glimmer of Hope. Rick Doblin Speaks with James Baldwin
Rick Doblin speaks with James Baldwin, Ph.D., Executive Director of the WIRB. Dr. Baldwin apologized for the tone of the WIRB letter and seemed to view favorably MAPS’ arguments. He was informed …
Outrageous News
Dr. George Ricaurte publishes an article in Science reporting on primate data that he claims suggests that even one night’s recreational use of Ecstasy can lead to Parkinson’s. This government-funded …
John Mendelson, M.D., Comments on MDMA Study Proposal
John Mendelson, M.D., Associate Professor at University California San Francisco, commented on Michael Mithoefer, M.D.s proposed MDMA study. Mendelson states that the risk of heart valve changes after …
MDMA Research Update: September 2002 – Terrible News: The Western IRB Approval Withdrawn
The Western IRB, which approved the MDMA/PTSD protocol on July 10, informed us by letter that approval was withdrawn. The revocation was based on secondhand reports of conversations (not on data!) that …
We received word that the Institutional Review Board (IRB) had approved MAPS MDMA/PTSD study
On July 10, we received word that the Institutional Review Board (IRB) had approved MAPS’ MDMA/PTSD study! We can now definitely say that the US study will take place. Dr. Michael Mithoefer still …
MDMA/PTSD protocol submitted to the Western Institutional Review Board
MDMA/PTSD protocol submitted to the Western Institutional Review Board (WIRB). Review expected to take 3-5 weeks.
FDA gives final approval to conduct the treatment sessions
FDA gives final approval to conduct the treatment sessions in Dr. Michael Mithoefer’s office, with a “crash cart” and an Emergency Room doctor and nurse in the next room in case they …
Conference call with Dr. Mithoefer, Rick Doblin and FDA officials
Conference call with Dr. Mithoefer, Rick Doblin and FDA officials, in which we come to tentative agreement to conduct the study in Dr. Mithoefer’s office, as long as we hire both an ER doctor and …
FDA Rejects Our Request
FDA rejects our request, primarily saying that they would like a larger emergency response team.
